Malaysian Genomics Signs MoU with Ajlan to explore distribution of biopharmaceutical and genetic screening services in MENA region
Malaysian Genomics Signs MoU with Ajlan to explore distribution of biopharmaceutical and genetic screening services in MENA region

PETALING JAYA, Malaysia, Aug 29, 2022 – (ACN Newswire via SEAPRWire.com) – Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, today announced that the Group has signed a Memorandum of Understanding (MoU) to explore opportunities for the distribution of biopharmaceutical and genomics products and services with Ajlan & Bros... » read more

Malaysian Genomics to Offer First-Ever Sports-Based Tests Specific to Southeast Asian Genetic Profiles
Malaysian Genomics to Offer First-Ever Sports-Based Tests Specific to Southeast Asian Genetic Profiles

PETALING JAYA, Malaysia, Jul 6, 2022 – (ACN Newswire via SEAPRWire.com) – Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, is pleased to announce that the Group’s wholly-owned subsidiary, MGRC Therapeutics Sdn Bhd (MGRCT), is collaborating with Rinani Genotec Sdn Bhd (Genotec) to offer sports-based genetic tests. Genotec, a... » read more

Personalised Health Supplements Customised from Genetic Screening Results Offered on airasia Super App

Malaysian Genomics, airasia Super App, Speedoc and Unique Remedy Join Hands to Offer Health Solutions to airasia Super App’s 51 Mil Users PETALING JAYA, Malaysia, Apr 6, 2022 – (ACN Newswire) – Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical company, is pleased to announce the launch of its genetic screening plus personalised health... » read more

Basecare Announces 2021 Annual Results: Overall Increase in Revenue and Gross Profit
Basecare Announces 2021 Annual Results: Overall Increase in Revenue and Gross Profit

HONG KONG, Mar 31, 2022 – (ACN Newswire via SEAPRWire.com) – Suzhou Basecare Medical Corporation Limited (“Basecare” or the “Company”, together with its subsidiaries, the “Group”, stock code: 2170), an innovative platform of genetic testing solutions for assisted reproduction in China, announced its audited consolidated results for the year ended 31 December 2021 (the “Year”).... » read more

Fujitsu, Kyoto University Develop Explainable AI Verification System for Estimating Disease-Causing Potential of Genetic Mutations
Fujitsu, Kyoto University Develop Explainable AI Verification System for Estimating Disease-Causing Potential of Genetic Mutations

TOKYO, Mar 11, 2021 – (JCN Newswire via SEAPRWire.com) – Fujitsu Limited and a Kyoto University research group led by Professor Yasushi Okuno of the Kyoto University Graduate School of Medicine, has developed an AI verification system called “MGeND Intelligence”. When the genetic mutation(1) information of a patient is input into this system, its ability... » read more